Proteon Pharmaceuticals otrzymał grant w wysokości 2,9 mln euro na rozwój bakteriofagowego produktu akwakultury
Polish biotech company Proteon Pharmaceuticals S.A, a global leader in the development and commercialization of bacteriophages for industrial use in livestock farming in poultry, dairy and aquaculture, has been awarded 2,9 mln Euro by the European Regional Development Fund to design and implement products that reduce the need for antibiotics in the human food chain.